Deciphera Pharmaceuticals, Inc.

DCPHNASDAQHealthcare

$25.59

+$0.02(+0.08%)

Market Cap$2.2B

P/E Ratio—

52W High$25.61

52W Low$9.9

Avg Volume1.9M

Open$25.56

Beta0.18

Employees Ownership Insider Trades

Deciphera Pharmaceuticals, Inc. (DCPH) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · DCPH · as of Feb 7, 2024

Latest filing snapshot

355

+55+18.33%vs prior year

Deciphera Pharmaceuticals, Inc. (DCPH) employee data is sourced from the annual SEC 10-K filing. As of 2023, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2023-12-31·Full-time · Global

Total Employees

355

Change (1Y)

+55

Growth % (1Y)

+18.33%

Revenue / Employee

$460.2K

Net Income / Employee

$-549.1K

Market Cap

$2.2B

DCPH Employee Count

2017 – 2023 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2024-02-07	2023-12-31	355	+55	+18.33%
2023-02-07	2022-12-31	300	+20	+7.14%
2022-02-08	2021-12-31	280	-70	-20.00%
2021-02-09	2020-12-31	350	+95	+37.25%
2020-03-09	2019-12-31	255	+143	+127.68%
2019-03-14	2018-12-31	112	+49	+77.78%
2018-03-28	2017-12-31	63	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Drug Manufacturers - Specialty & Generic

#SymbolCompanyEmployeesMkt Cap

Deciphera Pharmaceuticals, Inc.YOU

355$2.2B #3

CALT

Calliditas Therapeutics AB (publ)

222$2.1B #4

KDNY

Chinook Therapeutics, Inc.

214$2.7B #5

FUSN

Fusion Pharmaceuticals Inc.

101$1.8B #6

DICE

DICE Therapeutics, Inc.

71$2.3B #7

LBPH

Longboard Pharmaceuticals, Inc.

50$2.3B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · DCPH peer comparison

About DCPH employees

DCPH Employees · Headcount

Deciphera Pharmaceuticals, Inc. (DCPH) employee data is sourced from the annual SEC 10-K filing. As of 2023, Deciphera Pharmaceuticals, Inc. had 355 full-time employees globally. Full-time employees only. Global consolidated headcount.

Deciphera Pharmaceuticals, Inc. employs 355 full-time employees as of the latest filing within the Drug Manufacturers - Specialty & Generic industry. Revenue per employee stands at $460,158, reflecting the company's operational efficiency.

Deciphera Pharmaceuticals, Inc.'s workforce increased by 55 (18.33%) in 2023 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Deciphera Pharmaceuticals, Inc.'s revenue per employee of $460,158 positions it among the notable performers in the Drug Manufacturers - Specialty & Generic sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

DCPH Employees · 5 questions

As of the latest SEC 10-K filing (2023), Deciphera Pharmaceuticals, Inc. had 355 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Deciphera Pharmaceuticals, Inc. employee counthow many employees does Deciphera Pharmaceuticals, Inc. haveDCPH total employees 2023

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2024-02-07